Acute respiratory failure is a frequent reason for admission to the intensive care unit (ICU). It is associated with high healthcare consumption and mortality. High-flow nasal oxygen (HFNO) improves comfort, reduces the risk of intubation and may reduce the risk of mortality in the most severe patients with acute hypoxemic respiratory failure compared with other oxygenation strategies. Therefore, HFNO is recommended as a first-line non-invasive oxygenation strategy in acute hypoxemic respiratory failure. The timing of weaning patients from HFNO is complex. On the one hand, failure to wean from HFNO is associated with prolonged duration of HFNO and prolonged ICU stay. On the other hand, continued HFNO in patients ready to be weaned may unnecessarily prolong ICU stay and contribute to overwhelming of ICU capacities. The overarching goal of this study is to identify the characteristics of patients in whom weaning from HFNO is not beneficial.
Study Type
OBSERVATIONAL
Enrollment
2,000
University Hospital Bordeaux
Bordeaux, France
University Hospital Limoges
Limoges, France
University Hospital Poitiers
Poitiers, France
Hospital-free days at day 90
The number of days alive out of hospital between pseudorandomization and D90. For patients who died, the hospital-free days at day 90 will be equal to 0.
Time frame: 90 days
Duration of intensive care unit (ICU) stay
The number of days spent in the ICU
Time frame: 90 days
ICU mortality
The number (and proportion) of patients who died in the ICU
Time frame: 90 days
Survival at day 90
The number (and proportion) of patients alive at day 90 from pseudorandomization
Time frame: 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.